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Summary
To increase production of the important pharmaceuti-
cal compound clavulanic acid, a b-lactamase inhibitor,
both random mutagenesis approaches and rational
engineering of Streptomyces clavuligerus strains
have been extensively applied. Here, for the first time,
we compared genome-wide gene expression of an
industrial S. clavuligerus strain, obtained through
iterative mutagenesis, with that of the wild-type strain.
Intriguingly, we found that the majority of the changes
contributed not to a complex rewiring of primary
metabolism but consisted of a simple upregulation of
various antibiotic biosynthesis gene clusters. A few
additional transcriptional changes in primary metabo-
lism at key points seem to divert metabolic fluxes to
the biosynthetic precursors for clavulanic acid. In
general, the observed changes largely coincide with
genes that have been targeted by rational engineering
in recent years, yet the presence of a number of pre-
viously unexplored genes clearly demonstrates that
functional genomic analysis can provide new leads
for strain improvement in biotechnology.
Introduction
Streptomyces clavuligerus is an important industrial
microorganism, which produces the b-lactam antibiotic
cephamycin C (Martín and Liras, 1989) and the
b-lactamase inhibitor clavulanic acid (Saudagar et al.,
2008). Clavulanic acid is produced worldwide on a large
scale, and co-formulated with amoxicillin in Augmentin
(Brogden et al., 1981). Two biotechnological strain optimi-
zation approaches have been utilized to increase the pro-
duction of clavulanic acid by the bacterium: rational
metabolic engineering and iterative optimization through
random mutagenesis and screening.
In the rational approach, a specific gene is knocked out
or overexpressed to divert metabolic fluxes towards the
antibiotic biosynthetic pathways. Arguably, the best
example comes from the work of Li and Townsend (2006),
who re-engineered the S. clavuligerus glycolytic pathway
by constructing a deletion mutant of the glyceraldehyde
3-phosphate dehydrogenase gene gap1 to increase the
pool of the clavulanic acid precursor glycerol 3-phosphate
(G3P). This doubled clavulanic acid production compared
to the wild-type. Overexpression of the regulatory proteins
CcaR and ClaR also led to clavulanic acid overproduction
(Hung et al., 2007), and the two strategies have recently
been combined successfully in a single strain (Jnawali
et al., 2010).
Yet, most or even all production strains that are used in
industry have been obtained by classical strain improve-
ment (Adrio and Demain, 2006), based on mutagenesis
with mutagens such as nitrosoguanidine (NTG). Little is
known about the exact genetic changes through which
high production titers are achieved in these mutants.
Recently, we published the genome sequence of S.
clavuligerus ATCC 27064 (Medema et al., 2010). We now
employed this information to perform a genome-wide tran-
scriptome study on an industrial production strain, which
has been generated from the ATCC 27064 type strain
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(Higgens and Kastner, 1971) by several iterations of
mutagenesis and screening, and produces clavulanic acid
at levels approximately 100¥ that of the wildtype. The
majority of observed changes consist of increased tran-
script levels of the antibiotic biosynthesis gene clusters.
These observations are in agreement with flux-balance
analysis (FBA) predictions using a constraint-based
genome-scale metabolic model constructed for S. cla-
vuligerus. However, we also detected some potentially
crucial transcript level changes in primary metabolism that
could contribute to the increased production of clavulanic
acid by redirection of fluxes, mimicking strategies utilized
in rational approaches.
Results and discussion
Increased transcription of secondary metabolite
biosynthesis gene clusters in strain DS48802
Comparing gene transcript levels of S. clavuligerus wild-
type and DS48802 strains during stationary phase using
microarrays, almost all genes ranking high in a differential
transcriptome analysis belong to the complete clavulanic
acid/cephamycin C supercluster, which is significantly
overexpressed (between twofold and eightfold) in the
DS48802 strain compared to the wild-type. Interestingly,
the pathway-specific regulator genes claR and ccaR are
also overexpressed in DS48802. They are located within
the same supercluster and their products have been
shown to regulate it positively (Alexander and Jensen,
1998; Paradkar et al., 1998).
Additionally, the clavams gene cluster (cvm1245
and cas1) and the ‘paralogous’ alanylclavam cluster
(orfABCD and ceaS1/pah1/bls1/oat1) are significantly
overexpressed (Fig. 1), as is the two-component system
involving Cvm7p (SCLAV_p1079-p1080) that induces
expression of the alanylclavam cluster (Tahlan et al.,
2007). This suggests the presence of a regulatory
mechanism common to all these clusters. CcaR is an
unlikely candidate for such a common regulatory factor,
as it does not appear to control the paralogous cluster
(Tahlan et al., 2004); the pleiotropic regulator AdpA
Fig. 1. Differential gene expression in S. clavuligerus DS48802 and ATCC 27064.
Sliding window plot (size = 50) of the difference in gene expression between S. clavuligerus DS48802 and wild-type ATCC 27064. Key
upregulated operons or genes at the peaks are noted in the figure. See Table S2 for description of the ten gene clusters shown.
For gene expression analysis, cultivations were performed in shake flasks directly inoculated with spore suspensions at 28°C and 280 r.p.m.
The semi-synthetic growth medium used consisted of 30 g l-1 glycerol, 5 g l-1 wheat gluten, 3.5 g l-1 asparagine monohydrate, 1.5 g l-1 L-lysine,
0.7 g l-1 KH2PO4, 0.3 g l-1 MgSO4·7H2O, 0.2 g l-1 CaCl2·2H2O, 0.2 g l-1 FeSO4·7H2O, 10 g l-1 MOPS, 0.1 ml l-1 Basilodon and 1 ml l-1 trace
elements solution at pH 7.0. The trace element solution consisted of 20.4 g l-1 H2SO4, 50 g l-1 citric acid H2O, 16.75 g l-1 ZnSO4·7H2O,
1.6 g l-1 CuSO4. 5 H2O, 1.5 g l-1 MnCl2·4H2O, 2 g l-1 H3BO3 and 2 g l-1 Na2MoO4·2H2O. After 70 h of cultivation, the cells were harvested by
centrifugation, treated with RNAprotect (Qiagen) and directly frozen with liquid nitrogen and stored at -80°C. To isolate total RNA, the frozen
mycelium was ground in a mortar, resuspended in TE buffer with 5 mg l-1 lysozyme and incubated for 5 min at room temperature. RNA
isolation and purification were performed using phenol extraction (TRIzol reagent, Invitrogen) and RNeasy Kit (Qiagen). The RNA was
quantified by measuring the absorbance at 260 nm. Biotinylated cDNA was prepared after fragmentation according to the standard Affymetrix
protocol using GC rich (average 72%) primers from 10 mg total RNA. For hybridization, 5 mg and 7 mg biotinylated cDNA were used per
Affymetrix gene Chip. Microarray data have been deposited at Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) under accession
number GSE24033.
Flux-balance analysis was performed using a recently published genome-scale metabolic model of S. clavuligerus (Medema et al., 2010). In
this study, we slightly changed our objective function and included both clavulanic acid and cephamycin C biosynthesis pathways. We
dynamically changed the antibiotic concentration in the biomass composition based on experimental observations of Romero and colleagues
(1984) and optimized the objective function for different concentrations of each antibiotic. Among the 785 genes that the model contains, 497
genes showed non-zero flux for at least one antibiotic concentration. We calculated Spearman correlation of fluxes of each reaction with
increasing antibiotic concentrations. If an enzyme was involved in multiple reactions, we assigned the flux which had the highest r2.
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(SCLAV_1957) is a more likely candidate, as it is known
to induce clavulanic acid expression (Lopez-García
et al., 2010) and its gene is transcribed almost 2.5 times
stronger in DS48802.
In contrast to, for example, the intrachromosomal ampli-
fication of the kanamycin biosynthesis gene cluster in
Streptomyces kanamyceticus (Yanai et al., 2006), hybrid-
ization of S. clavuligerus DS48802 genomic DNA to the
microarrays revealed no amplifications of genes or gene
clusters (data not shown). The overproduction that we
observe therefore appears to be caused by transcriptional
(and post-transcriptional) changes only.
Flux-balance analysis of increased clavulanic acid
production correlates well with transcriptomic data
While many changes have occurred during the generation
of the DS48802 strain through mutagenesis, it is impor-
tant to note that changes in transcription levels of many
genes may be due to random mutations that have no
impact on antibiotic biosynthesis. In order to assess
which changes could be causatively linked to antibiotic
overproduction, we computationally predicted the
metabolic fluxes during antibiotic overproduction, using
a constraints-based genome-scale metabolic network
model of S. clavuligerus (Medema et al., 2010). We
dynamically modelled the metabolic flux changes during
increased production of clavulanic acid and cephamycin
C with different rates of antibiotic production relative to the
biomass, based on the experimental observations of
Romero and colleagues (1984). Interestingly, the compu-
tational predictions made through dynamic FBA are
largely in line with the observed expression changes.
Eighty-seven genes were predicted to be upregulated
(positively correlated with antibiotic production; r > 0.6)
and 129 genes were predicted to be downregulated
(negatively correlated; r < -0.6) at increasing antibiotic
production levels. Forty per cent (15/37) of the genes
that actually showed increased transcript levels (fold
change > 2) were also predicted to do so according to
FBA, and these include all genes encoding key biosyn-
thetic enzymes known to be involved in clavulanic acid
and cephamycin C biosynthesis. Even though 40% does
not appear to be a very large percentage, these predic-
tions are statistically very significant according to a Fish-
er’s exact test (P = 0.0005; see Table S1). One should
note that FBA predicts the flux for every reaction, not for
every gene product, as multiple gene products can be
involved in a single reaction. Therefore, in these cases the
same flux was assigned to all gene products involved in
that particular reaction, which is not necessarily the case
in the actual gene expression, as only a single homologue
or isoenzyme could be actively performing the reaction
and thus would be differentially expressed. Out of the 47
different enzymatic reactions predicted to be upregulated
(associated with 87 genes), 26 (55%) have at least one
gene linked to them, which showed increased transcript
levels. As both our FBA and gene transcript analysis
pointed to an increased expression of the clavulanic acid
and cephamycin core biosynthesis genes, we suggest
that this is a crucial change required for antibiotic over-
production in this strain. Moreover, as the FBA indicated
that the absolute fluxes required for high production of the
secondary metabolites are minor compared to other
fluxes involved in maintenance and cellular growth, a
complete redirection of primary metabolism appears not
to be necessary for overproduction.
Gene expression changes in primary metabolism
Nonetheless, because clavulanic acid is synthesized from
the precursors G3P and L-arginine, which play important
roles in primary metabolism, specific changes in the
primary metabolism of DS48802 could have occurred
during the various random mutagenesis rounds, so that
the intracellular pools of these intermediates are
increased.
Indeed, glycerol uptake and metabolism (SCLAV_0631-
0632 and SCLAV_0877-0879) is clearly upregulated over
twofold in DS48802, indicating an improved utilization of
glycerol as a carbon source as well as increased produc-
tion of the clavulanic acid precursor G3P (Fig. 2). More-
over, the aconitase and citrate synthase from the citric
acid cycle appear to be downregulated. A likely explana-
tion for this is that the carbon flux from G3P in this direc-
tion is reduced and is partly redirected to clavulanic acid
biosynthesis. This situation is remarkably similar to the
result of the rationally constructed gap1 deletion that
blocked G3P conversion into 1,3-bisphosphoglycerate,
thus improving clavulanic acid biosynthesis by increasing
the intracellular G3P pool (Li and Townsend, 2006).
However, an advantage of the situation in DS48802,
which seems to have an incomplete downregulation of the
flux, could be that a considerable pool of acetyl-CoA is
maintained, e.g. for the biosynthesis of ornithine from
glutamate. DS48802 also seems to avoid the potential
negative effects of a complete deletion of the aconitase
and citrate synthase genes: a complete absence of these
enzyme activities could lead to acidogenesis with nega-
tive consequences for secondary metabolite production
as shown by Viollier and colleagues (2001a,b). Moreover,
DS48802 still seems to be able to synthesize
a-ketoglutarate (a co-substrate required for clavaminic
acid biosynthesis; Salowe et al., 1990), while achieving
the benefits of higher acetyl-CoA and/or G3P pools that
have made these genes attractive targets for rational
engineering to improve antibiotic production (Viollier et al.,
2001a). A potentially important observation that we cannot
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explain yet from the current data are the differential tran-
script level changes of the two pyruvate kinase isoenzyme
genes, one being downregulated (SCLAV_4329) and the
other being upregulated (SCLAV_1203).
We also observed a remarkable upregulation of
glutamine synthetases I and II (SCLAV_1416 and
SCLAV_1431), glutamate synthetases (SCLAV_1231) and
glutamate importers (SCLAV_4660-4663). Glutamate can
serve as a source for biosynthesis of the clavulanic acid
precursor arginine. This conversion takes place through
the urea cycle involving ornithine as an intermediate
(Rodríguez-García et al., 2000), addition of which to the
medium has been shown to strongly enhance clavulanic
acid biosynthesis (Cheng et al., 2003). Probably to over-
come nitrogen and phosphate limitations, genes encoding
the transporters for ammonia (SCLAV_4534) and phos-
phate (SCLAV_3166-3169) are also observed to be more
highly transcribed in DS48802. This may be caused by the
Fig. 2. Changes in S. clavuligerus primary and secondary metabolism affecting clavulanic acid production.
Changes in gene expression in S. clavuligerus DS48802 compared to the wild-type ATCC 27064 projected onto a metabolic map. Green
arrows represent reactions catalyzed by genes expressed over twofold higher in DS48802 than in the wild-type. Red arrows represent
reactions catalyzed by genes expressed over twofold lower in DS48802. The orange arrow represents the reaction catalyzed by pyruvate
kinase, for which two isoenzymes exist which have changed in expression differently, one being downregulated (SCLAV_4329) and the other
being upregulated (SCLAV_1203). Black arrows represent unchanged steps; solid arrows represent single biosynthetic steps; and dashed
arrows represent multiple steps.
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increased expression of the pathway-specific activator
genes phoU (SCLAV_3220, Ghorbel et al., 2006) and glnB
(SCLAV_4535, Drepper et al., 2003), which both show
over twofold increased transcription.
Conclusions
Our data show that a strain improvement program by
random mutagenesis and screening has caused gene
transcript changes in both primary and secondary
metabolism. The overlap with results obtained by rational
metabolic engineering through claR/ccaR overexpression
and gap1 deletion is intriguing. New leads from transcript
changes observed in this study, such as the increased
transcription of glutamine and glutamate synthetase
genes, and of those encoding ammonium and phosphate
transporters, can now be combined to rationally design
novel high-producer strains. This approach might avoid
the introduction of unwanted adverse effects from random
mutagenesis, and provide strains suited for industrial
application in a more efficient way. In this manner, func-
tional genomics allows two key strategies applied in
biotechnology – random mutagenesis and rational
engineering – to become increasingly complementary.
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